GP

Gen Pharmaceuticals

Europe, Ankara, Turkey, Ankara

Description

This company is a pharmaceutical sector with the drugs used in the treatment of rare diseases.

Investor Profile

Gen Pharmaceuticals has made 2 investments, with 0 in the past 12 months and 50% as lead.

Stage Focus

  • Series B (50%)
  • Series A (50%)

Country Focus

  • United States (50%)
  • Turkey (50%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Gen Pharmaceuticals frequently co-invest with?

CH
North America, Pennsylvania, United States, Radnor
Co-Investments: 1
NewSpring Ventures
North America, Pennsylvania, United States, Radnor
Co-Investments: 1
İP
Europe, Istanbul, Turkey, Besiktas
Co-Investments: 1
Eczacıbasi Momentum
Europe, Istanbul, Turkey, Istanbul
Co-Investments: 1
EE
North America, New Jersey, United States, Bedminster
Co-Investments: 1

What are some of recent deals done by Gen Pharmaceuticals?

RS Research

Istanbul, Istanbul, Turkey

RS Research is a pharmaceutical company developing next generation of nanomedicines based on an innovative drug delivery platform.

BiotechnologyPharmaceutical
Series ADec 15, 2021
Amount Raised: $12,000,000
EKR Therapeutics

Bedminster, New Jersey, United States

EKR Therapeutics provides a segment of the healthcare market with products to improve patient outcomes and quality of life.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series BJul 3, 2006
Amount Raised: $5,000,000